These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33463683)

  • 21. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus.
    Hedberg P; Johansson N; Ternhag A; Abdel-Halim L; Hedlund J; Nauclér P
    BMC Infect Dis; 2022 Jan; 22(1):108. PubMed ID: 35100984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia.
    Voiriot G; Visseaux B; Cohen J; Nguyen LB; Neuville M; Morbieu C; Burdet C; Radjou A; Lescure FX; Smonig R; Armand-Lefèvre L; Mourvillier B; Yazdanpanah Y; Soubirou JF; Ruckly S; Houhou-Fidouh N; Timsit JF
    Crit Care; 2016 Oct; 20(1):375. PubMed ID: 27852281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study.
    Mendelson F; Griesel R; Tiffin N; Rangaka M; Boulle A; Mendelson M; Maartens G
    BMC Infect Dis; 2018 Aug; 18(1):399. PubMed ID: 30107791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of copeptin in distinguishing COVID-19 pneumonia from community-acquired pneumonia.
    Kuluöztürk M; İn E; Telo S; Karabulut E; Geçkil AA
    J Med Virol; 2021 May; 93(5):3113-3121. PubMed ID: 33570194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral respiratory infections: a cause of community-acquired pneumonia or a predisposing factor?
    Arnold FW; Fuqua JL
    Curr Opin Pulm Med; 2020 May; 26(3):208-214. PubMed ID: 32068577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procalcitonin in children admitted to hospital with community acquired pneumonia.
    Moulin F; Raymond J; Lorrot M; Marc E; Coste J; Iniguez JL; Kalifa G; Bohuon C; Gendrel D
    Arch Dis Child; 2001 Apr; 84(4):332-6. PubMed ID: 11259234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
    Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
    Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia.
    Menéndez R; Méndez R; González-Jiménez P; Latorre A; Reyes S; Zalacain R; Ruiz LA; Serrano L; España PP; Uranga A; Cillóniz C; Gaetano-Gil A; Fernández-Félix BM; Pérez-de-Llano L; Golpe R; Torres A
    Sci Rep; 2024 Jun; 14(1):12726. PubMed ID: 38830925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
    Agnello L; Bellia C; Di Gangi M; Lo Sasso B; Calvaruso L; Bivona G; Scazzone C; Dones P; Ciaccio M
    Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procalcitonin levels predict infectious complications and response to treatment in patients undergoing cytoreductive surgery for peritoneal malignancy.
    Saeed K; Dale AP; Leung E; Cusack T; Mohamed F; Lockyer G; Arnaudov S; Wade A; Moran B; Lewis G; Dryden M; Cecil T; Cepeda JA
    Eur J Surg Oncol; 2016 Feb; 42(2):234-43. PubMed ID: 26560024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial prescription in severe COVID-19 and CAP: a matched case-control study.
    Fierens J; De Bus L; Colpaert K; Boelens J; Gadeyne B; Decruyenaere J; Van Braeckel E; Depuydt P
    Acta Clin Belg; 2022 Oct; 77(5):837-844. PubMed ID: 34709997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Plasma D-Dimer in Adult Community-Acquired Pneumonia Patients is Associated with an Increased Inflammatory Reaction and Lower Survival.
    Ge YL; Liu CH; Wang N; Xu J; Zhu XY; Su CS; Li HL; Zhang HF; Li ZZ; Li HL; Zhang X; Chen H; Yu HL; Fu AS; Wang HY
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
    Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
    Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of C-reactive protein in the diagnosis, prognosis and follow-up of community-acquired pneumonia].
    Bauer S; Lamy O
    Rev Med Suisse; 2010 Nov; 6(269):2068-70, 2072-3. PubMed ID: 21140960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia.
    Ito A; Ishida T; Tachibana H; Arita M; Yamazaki A; Washio Y
    Clin Chem Lab Med; 2019 Sep; 57(10):1632-1637. PubMed ID: 31120857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited usefulness of initial blood cultures in community acquired pneumonia.
    Corbo J; Friedman B; Bijur P; Gallagher EJ
    Emerg Med J; 2004 Jul; 21(4):446-8. PubMed ID: 15208227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
    Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
    Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
    Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
    Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.